These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 15377354)

  • 1. Comparison of the expression of p53, p21, Bax and the induction of apoptosis between patients with basal cell carcinoma and normal controls in response to ultraviolet irradiation.
    Murphy M; Mabruk MJ; Lenane P; Liew A; McCann P; Buckley A; O Flatharta C; Hevey D; Billet P; Robertson W; Javed S; Leader M; Kay E; Murphy GM
    J Clin Pathol; 2002 Nov; 55(11):829-33. PubMed ID: 12401820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.
    Pilloni L; Bianco P; Manieli C; Senes G; Coni P; Atzori L; Aste N; Faa G
    Eur J Histochem; 2009; 53(2):e14. PubMed ID: 19683985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of CD56 and Smooth Muscle Actin Expression in Basal and Squamous Cell Carcinomas.
    Yirmibes S; Balaban Adim S
    Am J Dermatopathol; 2023 Dec; 45(12):816-819. PubMed ID: 37982465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ultrasound features with Bcl-2 protein expression in basal cell carcinomas (BCCs).
    Luo PP; Chen YX; Zhong ZR; Feng MC; Wang J; Liang JF
    J Clin Ultrasound; 2023; 51(9):1615-1621. PubMed ID: 37680166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands.
    Rostamizadeh L; Molavi O; Rashid M; Ramazani F; Baradaran B; Lavasanaifar A; Lai R
    Bioimpacts; 2022; 12(3):261-290. PubMed ID: 35677663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XZ-1 regulates cell apoptosis of gastric epithelial dysplasia via NF-κB/p53/Ki67 signaling pathway.
    Xu B; Zhang AM; Li F; Cui M; Han J; Cao Q
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29588340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial.
    Kessels J; Voeten L; Nelemans P; Cleutjens J; Hillen LM; Mosterd K; Kelleners-Smeets NWJ
    JAMA Dermatol; 2017 Oct; 153(10):1061-1063. PubMed ID: 28793140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.
    Karashima T; Udaka K; Niimura M; Suzuki K; Osakabe H; Shimamoto T; Fukata S; Inoue K; Kuroda N; Seiki M; Shuin T
    Oncol Lett; 2017 Jul; 14(1):1162-1166. PubMed ID: 28693290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines.
    Patchett AL; Darby JM; Tovar C; Lyons AB; Woods GM
    PLoS One; 2016; 11(12):e0168068. PubMed ID: 27936237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of p53 and Ki67 expression in skin epithelial tumors.
    Khodaeiani E; Fakhrjou A; Amirnia M; Babaei-Nezhad S; Taghvamanesh F; Razzagh-Karimi E; Alikhah H
    Indian J Dermatol; 2013 May; 58(3):181-7. PubMed ID: 23723466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldara activates TLR7-independent immune defence.
    Walter A; Schäfer M; Cecconi V; Matter C; Urosevic-Maiwald M; Belloni B; Schönewolf N; Dummer R; Bloch W; Werner S; Beer HD; Knuth A; van den Broek M
    Nat Commun; 2013; 4():1560. PubMed ID: 23463003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.
    de C Monteiro JS; de Oliveira SC; Reis Júnior JA; Gurgel CA; de Souza SC; Pinheiro AL; dos Santos JN
    Lasers Med Sci; 2013 May; 28(3):1017-24. PubMed ID: 22941426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer and the solid organ transplant recipient.
    Patel MJ; Liégeois NJ
    Curr Treat Options Oncol; 2008 Dec; 9(4-6):251-8. PubMed ID: 19225892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bowen's disease - a review of newer treatment options.
    Neubert T; Lehmann P
    Ther Clin Risk Manag; 2008 Oct; 4(5):1085-95. PubMed ID: 19209288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatments for basal cell carcinoma.
    Lee S; Selva D; Huilgol SC; Goldberg RA; Leibovitch I
    Drugs; 2007; 67(6):915-34. PubMed ID: 17428108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.